Artisan Partners
DYN icon

Artisan Partners’s Dyne Therapeutics DYN Stock Holding History

Artisan Partners’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.2M Sell
619,457
-30,234
-5% -$521K 0.02% 297
2025
Q4 		$12.7M Buy
+649,691
New +$12.3M 0.02% 309

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Artisan Partners's DYN Position: Q1 2026 in Review

Artisan Partners reduced its Dyne Therapeutics (DYN) stake by 4.7% in Q1 2026, selling an estimated $521K and leaving 619,457 shares worth $11.2M. The position accounts for 0.02% of the portfolio, ranked #297.

Artisan Partners first reported a position in DYN in Q4 2025 and has held it in 2 quarters since. The position peaked at $12.7M in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Artisan Partners held 619,457 shares of Dyne Therapeutics worth $11.2M as of Q1 2026.
  • Artisan Partners sold 30,234 Dyne Therapeutics shares in Q1 2026, an estimated $521K.
  • Dyne Therapeutics made up 0.02% of Artisan Partners's portfolio in Q1 2026, its #297 holding.
  • Artisan Partners first reported a position in Dyne Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Artisan Partners's Dyne Therapeutics position peaked at $12.7M in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Artisan Partners's 13F filing for Q1 2026, filed 13 May 2026.